Technology firms are leveraging AI, machine learning and wearables to improve the diagnosis and management of sleep apnea, a common but often undiagnosed condition affecting millions of people globally. The FDA has cleared an AI algorithm from EnsoData to help diagnose sleep disorders using any FDA-cleared pulse oximeter, while Samsung received De Novo approval for a Galaxy Watch oxygen sensor. Additionally, the National Institutes of Health has granted $4.1m to Mount Sinai to develop an AI model to generate a risk profile for sleep apnea patients.
$14M more for EMR implementation in Victoria and more briefs
Victoria’s government is investing A$21.4 million to replace paper-based medical records with electronic systems in four health services, including The Royal Eye and Ear Hospital
